|Articles|October 2, 2015
Teva to Buy Leading Mexican Pharma Firm
October 02, 2015.
Advertisement
Teva (Petah Tikva, Israel) has entered into an agreement to acquire Mexican pharma company Representaciones e Investigaciones Médicas (Rimsa) for $2.3 billion,
Rimsa, which had a 2014 revenue of $227 million, has a portfolio of specialty products, including fixed-dose combination products. The company has a 45-year history as one of Mexico's companies; Mexico is the second largest healthcare market in Latin America.
Teva expects to close the transactions by Q1 2016.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
What Pharma Investors Should Expect in the Current Regulatory Environment
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5